Effect of Obesity on Outcomes after Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
Authors:
Open Access
- 1 December 2011
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 17 (12) , 1765-1774
Abstract
No abstract availableKeywords
Funding Information
- American Society of Hematology (K23CA130074)
- Leukemia and Lymphoma Society
- National Cancer Institute
This publication has 36 references indexed in Scilit:
- Relationship Between Obesity and Pathologic Response to Neoadjuvant Chemotherapy Among Women With Operable Breast CancerJournal of Clinical Oncology, 2008
- Chemotherapy Dosing Strategies in the Obese, Elderly, and Thin Patient: Results of a Nationwide SurveyJournal of Oncology Practice, 2008
- Obesity and Outcome in Pediatric Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2007
- Body Mass and Mortality After Breast Cancer DiagnosisCancer Epidemiology, Biomarkers & Prevention, 2005
- Obesity and Outcomes in Premenopausal and Postmenopausal Breast CancerCancer Epidemiology, Biomarkers & Prevention, 2005
- Influence of body mass index on outcomes and treatment‐related toxicity in patients with colon carcinomaCancer, 2003
- Impact of obesity in the setting of high-dose chemotherapyBone Marrow Transplantation, 2003
- Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograftBone Marrow Transplantation, 2000
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONBritish Journal of Haematology, 1998
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958